All You Need To Know About-Juvenile Diabetes-Boise City-Type None Diabetes
Type 1 diabetes (T1D) is an autoimmune disease in which a person’s pancreas stops producing insulin. It occurs when the body’s immune system attacks and destroys the insulin-producing cells in the pancreas, called beta cells. While its causes are not yet entirely understood, scientists believe that both genetic factors and environmental triggers are involved. Its onset has nothing to do with diet or lifestyle. There is nothing you can do to prevent T1D, and—at present—nothing you can do to get rid of it.
While people with T1D rely on insulin therapy to control their blood sugar, insulin is not a cure nor does it prevent the possibility of the disease’s serious side effects. Even with intensive disease management, a significant portion of their day is still spent with high or low blood-sugar levels, placing people with T1D at risk for devastating complications such as heart attack, stroke, blindness, kidney disease and amputation. List of Video Credits can be found here http://broadcaster.beazil.net/public/credits/youtube/videos/42559 Boise, Idaho, the state capital, is the largest city in Idaho and the center of commerce and politics for the state. It is located in the foothills of the Rocky Mountains, and residents enjoy many outdoor activities from skiing to boating. The terrain surrounding the city is very mixed and includes desert, rivers, mountains, and lakes. Boise State University is found in the city and has over 15,000 students. Boise has a population of around 185,000 and the downtown area is at an elevation of 2704 feet. There are a number of large corporations that call Boise home, including Albertsons, Micron Technology, and Hewlett-Packard. Boise is known as the regional hub for music and performing arts. Jazz is big here, with the Gene Harris Jazz Festival happening every spring. JDRF is the world’s leading charitable funder of type 1 diabetes research and raise money to drive world class research. We aim to find new ways to treat type 1 diabetes and its complications, prevent type 1 from developing and find the cure for people who already have the condition. JDRF’s research mission is to discover, develop, and deliver advances that cure, better treat, and prevent T1D. As the global leader in the fight against T1D, JDRF’s research programs are comprehensive – addressing the hopes and dreams of every person with T1D for the best quality of life and a cure for this disease. Millions of people around the world live with type 1 diabetes (T1D), a life-threatening autoimmune disease that strikes both children and adults. There is no way to prevent it, and at present, no cure. The Health Care and Social Assistance industry includes establishments and services such as:
hospitals, nursing and residential care facilities and out-patient care centres; offices of health practitioners (i.e. dentists, doctors, optometrists and chiropractors); medical and diagnostic laboratories; home health care services; ambulance services; social assistance services (i.e. for children, youth, the elderly, families); community food, housing, emergency and relief services; vocational rehabilitation services; and daycare services JDRF is the leading global organization funding type 1 diabetes (T1D) research. JDRF’s goal is to progressively remove the impact of T1D from people’s lives until we achieve a world without T1D. JDRF has led the search for a cure for T1D since our founding in 1970. In those days, people commonly called the disease “juvenile diabetes” because it was frequently diagnosed in, and strongly associated with, young children. Our organization began as the Juvenile Diabetes Foundation. Later, to emphasize exactly how we planned to end the disease, we added a word and became the Juvenile Diabetes Research Foundation.Today, we know an equal number of children and adults are diagnosed every day—approximately 110 people per day.
To summarize, let’s point out the major points:
scientific community,Education,Team Cure Diabetes,Microvascular Complications,funding research,T1D patterns,get support,Beta Cell Health and Survival,Parents of children with T1D,hyperglycemia,Ketoacidosis,fasting lipid profile,oral hypoglycemic agents,Team Research,Estrogen in Type 1 Diabetes,diabetic kidney disease,Medical Research Council,insufficient insulin production,JDRF One Walk,insulin dependent,Affects of Diabetes,Nutrition,50/50 insulin,precise,Kussmaul breathing,cure therapies,amputation,SGLT2 inhibitors,diabetic retinopathy,diabetes self-management education,Short Acting Insulin,become a volunteer,fundraising,Hypoglycemia Prevention,Ride to Cure Diabetes,JDRF Mentor Program,Treating Type 1,diabetic myelopathy,glyburide,Abstracts of JDRF Research,Basal Insulin,Research funding,care delivery systems,Action in Diabetes and Vascular Disease: Preterax and Diamicron MR Controlled Evaluation Trial,DKA,Clinical Trials,get involved,Carol Lurie,donate to help,GLP-1 agonists,low blood.